{
    "2021-07-11": [
        [
            {
                "time": "",
                "original_text": "审批加速！AI医疗迎商业化元年，AI医疗第一股也要来了",
                "features": {
                    "keywords": [
                        "审批加速",
                        "AI医疗",
                        "商业化元年",
                        "第一股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "公告精选：锐科激光回应被美国商务部列入实体清单；金安国纪上半年净利预增逾5倍",
                "features": {
                    "keywords": [
                        "锐科激光",
                        "美国商务部",
                        "实体清单",
                        "金安国纪",
                        "净利预增"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "制造业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "雅培大裁员！疫情过后医械企业何去何从？",
                "features": {
                    "keywords": [
                        "雅培",
                        "裁员",
                        "疫情",
                        "医械企业"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-07-11",
                "original_text": "7月11日上市公司晚间公告速递",
                "features": {
                    "keywords": [
                        "上市公司",
                        "公告"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗：上半年净利润同比预增50%-70%",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "净利润",
                        "预增"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "新冠抗原试剂境外业务快速增长 乐普医疗(300003.SZ)半年度归母净利预增50%至70%",
                "features": {
                    "keywords": [
                        "新冠抗原试剂",
                        "境外业务",
                        "乐普医疗",
                        "归母净利",
                        "预增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗：上半年预计净利润同比增长50.0%~70.0%",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}